Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart DiseasesNews DeskJune 18, 20260 Cardiovascular disease drugs continue to rank among the most prescribed medicines, but there’s still leave plenty of unmet medical need.…